The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause.
Medscape Ob/Gyn …read more
The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause.
Medscape Ob/Gyn …read more